Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical Company Limited operates as a research-basedpharmaceutical company in Japan.
Suggest edits
Founded
1781
Raised
$57.8M
Follow us
Companies in the same industry
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2019
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2

Investments 12

Acquisitions 1

Apps 4

Add info
Add round
23 Nov 2017
Chordia Therapeutics
Chordia Therapeutics
Venture capital (Series A)
SMBC Venture Capital, Mitsubishi UFJ Capital, Takeda Pharmaceutical, +2
16 Aug 2017
Molecular Templates
Molecular Templates
$60,000,000
Post-IPO equity
Perceptive Advisors, Longitude Capital, Takeda Pharmaceutical, +2

https://www.bizjournals.com/austin/news/2017/08/16/austin-biotech-company-lands-on-nasdaq-with-fresh.html?ana=twt

bizjournals
+1
05 Jan 2017
Avidity Biosciences
Avidity Biosciences
$10,000,000
Venture capital (Series B)
EcoR1 Capital, Moore Venture Partners, F-Prime Capital Partners, +5

Avidity Biosciences Raises 16 Million In Series B Financing To Advance Antibody Sirna Conjugate Platform

biospace
+2
05 Jan 2017
PvP Biologics
PvP Biologics
$35,000,000
Venture capital
Takeda Pharmaceutical

PvP Biologics Raises $35M in a Lab-to-Pharma Deal with Takeda

Xconomy
+1
02 Dec 2016
Cerevance
Cerevance
$36,000,000
Venture capital (Series A)
Takeda Pharmaceutical, Lightstone Ventures

CEREVANCE LAUNCHED WITH NEW TECHNOLOGY, DRUG PORTFOLIO AND $36M IN CASH TO TACKLE BRAIN DISEASES Pharmaceutical Company Limited

takeda
16 Jun 2016
Mersana Therapeutics
Mersana Therapeutics
$33,000,000
Venture capital (Series C)
Wellington Management, NEA, Rock Springs Capital, +3

Booming Mersana Nabs Another 33 Million for a Total Take of 120 Million

biospace
+1
16 Mar 2016
Outpost Medicine
Outpost Medicine
$41,000,000
Venture capital (Series A)
Adams Street Partners, Frazier Healthcare Partners, Novo A/S, +2

Outpost Medicine raises $41 mln

PE Hub
+1
17 Jan 2016
Cortexyme
Cortexyme
$15,000,000
Venture capital (Series A)
Takeda Pharmaceutical, Pfizer

Cortexyme Raises $15M in Series A Financing

FinSMEs
30 Sep 2015
Encycle Therapeutics Inc
Encycle Therapeutics Inc
$2,850,000
Venture capital
BDC Capital, MaRS Investment Accelerator Fund, Takeda Pharmaceutical, +1

Encycle Therapeutics raises $2.85 million to expand development pipeline

BetaKit
17 Jan 2014
Seattle Genetics
Seattle Genetics
$9,000,000
Post-IPO equity
Takeda Pharmaceutical
28 Mar 2011
Alnylam
Alnylam
$10,000,000
Venture capital
Takeda Pharmaceutical